Sally Crossing’s recent article about the media’s overenthusiastic promotion of the breast cancer drug Herceptin rang some loud bells for my colleagues and I. We have analysed the media and political ...

Clinical Senior Lecturer at Deakin University School of Medicine & Pain Specialist, Barwon Health Australia’s oxycodone problem has thankfully not risen to the heights of the public health disaster ...

Richard De Abreu Lourenco receives funding from NHMRC, Cancer Australia, the Victorian Cancer Agency and the Department of Health. None of the views expressed in the piece relfect the views of those ...

Big drug companies have come under fire from the Federal Government for pushing expensive cancer medications that have limited benefit. In an explosive submission to a Senate inquiry, the medical ...